文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

脓毒症凝血相关基因的免疫浸润与临床特征分析

[Immune infiltration and clinical characteristics analysis of coagulation-related genes in sepsis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论生物信息学发现CD163可能是脓毒症免疫-凝血障碍的核心基因,动物实验中重组人血小板生成素可改善脓毒症-DIC大鼠的凝血与免疫指标。

该研究基于GEO数据库整合脓毒症数据集,纳入989例脓毒症样本和100例对照样本进行差异表达分析,筛选出59个凝血相关差异表达基因(CRDEG),其中25个在高危与低危组间有统计学差异。通过PPI网络和五种算法交集确定CCL5、MMP-9、CD8A、CCR5和CD163为关键基因,CD163诊断脓毒症的AUC为0.746,且与巨噬细胞强正相关。动物实验中,与脓毒症组相比,脓毒症-DIC组大鼠CD163+亚群升高、ADAMTS-13活性降低、vWF活性升高、miR-150下调和p65上调;重组人血小板生成素干预组上述指标有不同程度改善。

要点

  • 基于GEO数据库989例脓毒症样本和100例对照样本,筛选出59个凝血相关差异表达基因,25个在高危与低危组间有统计学差异(均P<0.05)。
  • CD163诊断脓毒症的ROC曲线AUC为0.746,CD163与巨噬细胞强正相关,可能是脓毒症免疫-凝血障碍的核心基因。
  • 脓毒症-DIC大鼠较脓毒症组CD163+外周血巨噬细胞亚群升高、ADAMTS-13活性降低、vWF活性升高、miR-150下调和p65上调。
  • 重组人血小板生成素干预组较脓毒症-DIC组ADAMTS-13为(6.44±1.24)% vs(1.87±0.40)、vWF为(224.80±26.19)% vs(394.10±22.54)%、miR-150为2.47±0.23 vs 0.97±0.19、p65为3.90±0.70 vs 7.71±0.63,均P<0.05。
  • 作者认为CD163上调、上游NF-κB信号分子上调及miR-150下调与脓毒症危重指标恶化和凝血障碍趋势一致,重组人血小板生成素可改善这些现象。

适用人群与场景

  • 生物信息学部分:基于GEO数据库整合的脓毒症数据集,989例脓毒症样本和100例对照样本。
  • 动物实验部分:15只雄性SD大鼠,随机分为脓毒症组、脓毒症-DIC组和重组人血小板生成素干预组,每组5只。

诊断标准与关键阈值

  • 根据脓毒症诊断模型中风险评分的中位数表达,将脓毒症样本分为高危组和低危组。

处置流程与药物剂量

  • 动物实验中,重组人血小板生成素干预组接受重组人血小板生成素干预,具体剂量、途径、频次及疗程原文未写明。

研究设计与关键结果

  • 生物信息学分析共获得59个凝血相关差异表达基因,其中25个在高危组与低危组间表达有统计学差异(均P<0.05)。
  • 通过五种算法交集确定关键基因为CCL5、MMP-9、CD8A、CCR5和CD163;5个关键基因在脓毒症样本与对照样本间表达均有统计学差异(均P<0.05),CD163和MMP-9与脓毒症正相关,其余3个基因负相关。
  • ROC曲线分析显示CD163表达水平诊断脓毒症的AUC为0.746;20种免疫细胞在高危组与低危组间浸润丰度有统计学差异(均P<0.05),CD163与巨噬细胞强正相关。
  • 调控网络分析显示,参与脓毒症凝血障碍的NF-κB可能调控CD163表达,与脓毒症凝血障碍相关的miR-150可能调控NF-κB和CD163。
  • 动物实验中,与脓毒症组相比,脓毒症-DIC组大鼠危重指标更差、凝血功能障碍加重,表现为外周血巨噬细胞CD163+亚群水平升高、血浆ADAMTS-13活性降低、vWF活性升高、外周血白细胞miR-150表达下调和p65表达上调。
  • 重组人血小板生成素干预组上述指标较脓毒症-DIC组有不同程度改善,两组间差异有统计学意义:ADAMTS-13为(6.44±1.24)% vs(1.87±0.40)、vWF为(224.80±26.19)% vs(394.10±22.54)%、miR-150(2-ΔΔCt)为2.47±0.23 vs 0.97±0.19、p65(2-ΔΔCt)为3.90±0.70 vs 7.71±0.63,均P<0.05。

证据类型、等级与局限

  • 证据类型:生物信息学分析联合动物实验验证。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为CD163可能是脓毒症免疫-凝血障碍的核心基因,CD163上调、上游NF-κB信号分子上调及miR-150下调与脓毒症危重指标恶化和凝血障碍趋势一致。
  • 作者认为重组人血小板生成素可改善脓毒症-DIC大鼠的上述现象。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To analyze the immune infiltration and critical characteristics of coagulation-related genes in sepsis, reveal the role of coagulation-related differentially expressed gene (CRDEG) in sepsis through large-scale data analysis, and explore the relationship between CRDEG and coagulopathy in sepsis as well as the potential targets.

METHODS: (1) Bioinformatics experiment: based on the Gene Expression Omnibus (GEO) database integrated from sepsis datasets, samples were divided into 989 sepsis samples and 100 control samples for differential expression analysis. The analysis results were intersected with coagulation-related genes obtained from gene-related databases to obtain CRDEG. According to the median expression of risk score in the sepsis diagnosis model, the sepsis samples were divided into a high-risk group and a low-risk group, and the difference of CRDEG expression between the two groups were compared. A CRDEG-related protein-protein interaction (PPI) network was constructed, and key genes were obtained through algorithm analysis, and the correlation between key genes and sepsis was analyzed, and the diagnostic value of key genes expression for sepsis was evaluated by receiver operator characteristic curve (ROC curve) analysis. The relative abundance of immune cells infiltrated in the high- and low-risk groups of sepsis was compared, and the correlation between key genes and immune cells was calculated based on the Spearman correlation analysis. The key gene mRNA-transcription factor (TF) and key gene mRNA-microRNA (miRNA) regulatory network were constructed to explore the changes in the signaling pathways to coagulopathy in sepsis.(2) Animal experiment verification: 15 male SD rats were randomly divided into a sepsis group, a sepsis-disseminated intravascular coulation (DIC) group and a human recombinant thrombopoietin (hrTPO) intervention group, with 5 rats in each group. The rats' critical indicators [platelet/lymphocyte ratio (PLR), prothrombin time (PT), fibrinogen (FIB), oxygenation index (PaO2/FiO2), base excess (BE), lactic acid (Lac)] were detected. The level of CD163 [the scavenger that internalizes ADAMTS-13 (von Willebrand factor-cleaving protease) on the surface of monocyte-macrophages] in peripheral blood was detected by flow cytometry. The activity of plasma ADAMTS-13 and von Willebrand factor (vWF) was detected by enzyme-linked immunosorbent assay (ELISA). The expression of microRNA-50 (miR-150) and p65 (nuclear transcription factor) in peripheral blood leukocytes was detected by reverse transcription-polymerase chain reaction (RT-PCR).

RESULTS: (1)Bioinformatics experiment results: finally, a total of 59 CRDEG were obtained. The expression levels of 25 CRDEG were statistically significant between the high-risk and low-risk groups of sepsis (all P<0.05). The PPI network of the 25 CRDEG was constructed, and the intersection of genes obtained based on five algorithms as key genes, which were chemokine CCL5, matrix metalloproteinase-9 (MMP-9), T-cell surface protein CD8A, chemokine receptor 5 (CCR5), and CD163, respectively. The expression levels of five key genes were statistically significant between the sepsis samples and the control samples (all P<0.05), among which key gene CD163 and MMP-9 were positively correlated with sepsis, and the other three genes were negatively correlated with it. ROC curve analysis showed that the CD163 expression level had a high accuracy in the diagnosis of sepsis [area under the ROC curve (AUC) was 0.746]. The immune infiltration abundance of 20 kinds of immune cells was statistically significant between the high- and low-risk groups of sepsis (all P<0.05). Correlation analysis showed that CD163 was strongly positively correlated with macrophages. Regulatory network analysis showed that nuclear factor-κB (NF-κB), which participates in the coagulopathy of sepsis, might regulate the expression of CD163 and the miR-150 related to coagulopathy in sepsis might regulate NF-κB and CD163. (2) Animal experimental verification results: compared with the sepsis group, the rats in the sepsis-DIC group had worse critical indicators, and coagulation function disorders were aggravated, which was manifested by the increased CD163+ subset levels in peripheral blood macrophages, decreased plasma ADAMTS-13 activity, increased vWF activity, downregulated miR-150 expression in peripheral blood white blood cells and upregulated p65 expression. The above indicators of the rats in the hrTPO intervention group were improved to varying degrees compared with the sepsis-DIC group, and there were statistically significant differences between the two groups [ADAMTS-13: (6.44±1.24)% vs. (1.87±0.40), vWF: (224.80±26.19)% vs. (394.10±22.54)%, miR-150 (2-ΔΔCt): 2.47±0.23 vs. 0.97±0.19, p65 (2-ΔΔCt): 3.90±0.70 vs. 7.71±0.63, all P<0.05].

CONCLUSIONS: By integrating the GEO dataset, CRDEG was identified, with CD163 potentially being the core gene involved in sepsis-induced immune-coagulopathy. The upregulation of macrophage CD163 and upstream NF-ΚB signaling molecules, coupled with the downregulation of miR-150, aligns with the deterioration of critical indicators of sepsis and the trend towards coagulopathy. However, hrTPO can ameliorate these phenomena.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Xing Y, Cheng M, Dong Y, et al. [Immune infiltration and clinical characteristics analysis of coagulation-related genes in sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 41833346. doi:10.3760/cma.j.cn121430-20250210-00080

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。